Indegene Limited (NSE: INDGN)
India flag India · Delayed Price · Currency is INR
640.90
+5.50 (0.87%)
Nov 21, 2024, 3:30 PM IST

Indegene Company Description

Indegene Limited operates as a life sciences commercialization company in India, the United States, Europe, and internationally.

It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, and Omnichannel Activation & Others.

The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies.

It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions.

In addition, the company operates NEXT technology platforms. Further, it provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations.

Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.

Indegene Limited
Country India
Founded 1998
Industry Health Information Services
Sector Healthcare
Employees 4,367
CEO Manish Gupta

Contact Details

Address:
Manyata Embassy Business Park
Bengaluru, Karnataka 560045
India
Phone 91 80 4674 4567
Website indegene.com

Stock Details

Ticker Symbol INDGN
Exchange National Stock Exchange of India
Fiscal Year April - March
Reporting Currency INR
ISIN Number INE065X01017
SIC Code 8731

Key Executives

Name Position
Manish Gupta BTech, MBA Chairman and Chief Executive Officer
Suhas Prabhu ACA, BCom Chief Financial Officer
Anand Kiran Prafula Chandra Nijegal Executive Vice President of Global Operations
Dr. Sanjay Suresh Parikh Ph.D. Executive Director and Executive Vice President
Marut Setia Senior Vice President of Global Growth Markets, Accounts and Medical Devices
Pankaj Kakkar Senior Vice President of Global Operations
Tarun Mathur Chief Technology Officer
Srishti Ramesh Kaushik Company Secretary and Compliance Officer
Karthik Kannappan Saravanan Vice President of Legal and Group General Counsel
Shouvanik Chatterjee Senior Vice President of Corporate Development